[
  {
    "question": "Female patient on 4 AED still has abnormal movements for more than 1 hr, normal prolonged EEG & MRI brain next?",
    "option_a": "Stop all AED",
    "option_b": "repeat prolonged EEG",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "In patients with a longstanding diagnosis of epilepsy who are on multiple anti\u2010seizure medications yet continue to exhibit abnormal paroxysmal movements, an important consideration is whether these events are truly epileptic in nature. Psychogenic non\u2010epileptic seizures (PNES) are a well-recognized mimic of epileptic seizures. PNES are thought to arise from psychological stressors and are classified as a type of functional neurological disorder. Unlike epileptic seizures, PNES lack the characteristic EEG abnormalities and are not accompanied by structural brain lesions on MRI. A female patient on four AEDs experiencing abnormal movements for more than one hour, coupled with a normal prolonged EEG and brain MRI, strongly suggests that these events are likely not epileptic. Instead, they may represent PNES, leading to unnecessary polypharmacy and potentially exacerbating side effects. The diagnostic workup for suspected PNES includes a comprehensive history, video EEG monitoring during an event, and sometimes psychological evaluation. Differential diagnoses include status epilepticus and complex partial seizures; however, normal EEG findings during an event strongly favor PNES. The current management approach for PNES involves gradually tapering and discontinuing ineffective AEDs while initiating a referral for psychiatric evaluation and cognitive behavioral therapy. For women, particularly those of childbearing age, minimizing unnecessary AED exposure is especially critical due to potential teratogenic risks. A tiered approach begins with validation of the diagnosis, patient education, and a carefully managed reduction of AEDs with close monitoring. Option A (Stop all AED) is the most appropriate choice among those provided, as it aligns with the need to discontinue inappropriate medications in a patient likely suffering from PNES. Option B (Repeat prolonged EEG) is unlikely to yield additional useful information after a thorough negative workup. The originally marked answer (Option C) seems to be an error since it does not correspond to a defined management step. 1. PNES should be suspected in patients with medication-refractory seizures who have normal EEG and imaging findings. 2. Discontinuing or tapering unnecessary AEDs is a key step once PNES is established. 3. A multidisciplinary approach including psychological therapies is essential for management. Recent guidelines emphasize the importance of correctly diagnosing PNES to avoid the morbidity associated with unnecessary AED exposure. The latest research supports a management strategy that focuses on gradual AED withdrawal and early psychiatric intervention, particularly in populations vulnerable to the adverse effects of polypharmacy, such as women of childbearing age.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Refractory Epilepsy Patient scheduled for EMU admission after 1 year waiting, the chairman called in to cancel the admission and schedule his relative instead who had a history of syncope?",
    "option_a": "call the chairman and discuss the case priority",
    "option_b": "Ignore him and admit your Patient",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question involves the ethical and professional management of scheduling in clinical practice. It highlights the importance of prioritizing patient care based on medical need and established waiting lists rather than personal relationships, as well as the necessity to address requests that may conflict with fairness and institutional policies. While not related to a biological disease process, the underlying mechanism here is the conflict between personal influence/authority and equitable patient care. The decision\u2010making process should be guided by ethical principles of justice, beneficence, and non\u2010maleficence. A patient with refractory epilepsy, who has been waiting one year for admission to the Epilepsy Monitoring Unit (EMU), is a high priority because they have a chronic, drug\u2010resistant condition that could severely impact quality of life. In contrast, a relative with syncope (often a benign complaint if not associated with high-risk features) is lower priority in this setting. The 'diagnosis' here is an ethical dilemma. Differential considerations include: a) outright defying the request (which may challenge institutional hierarchy), b) discussing scheduling priorities with the chairman, and c) unilaterally admitting the patient without addressing the override. The appropriate approach is to review and clarify scheduling priorities by engaging in discussion. The first step is to approach the situation by seeking clarification and discussing the case priority with the chairman. This ensures that the established criteria for EMU admission are maintained. In tiered management, one first verifies the facts and then advocates for the patient\u2019s rightful place. For all patient populations (including pregnant or lactating individuals), fairness and safety are paramount, and resource allocation should be based on medical urgency and evidence-based criteria. Option A ('call the chairman and discuss the case priority') is correct because it maintains professional decorum while addressing an unethical scheduling change. Option B ('Ignore him and admit your patient') might seem at first to support the patient\u2019s best interest but bypasses proper communication channels and does not resolve the ethical conflict, potentially undermining institutional procedures. 1. Always advocate for your patient by addressing conflicts through proper channels. 2. Ethical decision-making in resource allocation should be transparent and evidence\u2010based. 3. Upholding fairness and neutrality is key in avoiding nepotism. Recent discussions in medical ethics emphasize that appeals to fairness and transparency in scheduling and resource allocation are essential to maintaining trust in clinical practice. Institutional policies and ethical guidelines support a collaborative discussion with superiors when conflicts arise rather than taking unilateral action.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "question": "Young lady diagnosed with MTLE. She is on levetiracetam and carbamazepine. Last GTC seizure was couple of months ago but she came to clinic with episodes of partial unaware seizures occurs 1/month. What is the best next step?",
    "option_a": "Add 3rd AED",
    "option_b": "Shift to another 2 combination",
    "option_c": "Start epilepsy surgery workup",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "This question tests the management strategy for drug\u2010resistant mesial temporal lobe epilepsy (MTLE). Drug resistance is defined by failure to achieve seizure freedom after adequate trials of at least two appropriate antiepileptic drugs (AEDs). MTLE is often associated with mesial temporal sclerosis. When seizures persist despite optimal AED treatment, the underlying epileptogenic network is likely resistant to further medication adjustments. In such patients, surgical resection (typically anterior temporal lobectomy) offers a higher chance for seizure control. The patient, a young woman on both levetiracetam and carbamazepine, has a history of generalized tonic\u2013clonic seizures but now experiences monthly episodes of partial unaware seizures. This picture is consistent with drug\u2010resistant epilepsy despite a seemingly acceptable regimen, making her a candidate for surgical evaluation. The diagnostic evaluation includes video\u2010EEG monitoring, high\u2010resolution MRI to identify mesial temporal sclerosis or other lesions, and neuropsychological testing. Differential diagnoses might include poor medication adherence, suboptimal dosing, or coexistent non-epileptic events; however, the persistence of focal seizures despite 2 AEDs strongly supports refractoriness. First\u2010line management for proven drug\u2010resistant MTLE is a surgical workup, which includes detailed EEG, imaging studies, and neuropsychological assessment. Surgical resection is considered when there is a clear epileptogenic focus. For patients who are pregnant or who may become pregnant, planning a surgical approach may offer the potential to reduce lifelong exposure to multiple AEDs (many of which have teratogenic potential) and improve outcomes both for the mother and the fetus. Option A ('Add 3rd AED') is generally not recommended once two AEDs have failed. Option B ('Shift to another 2 combination') delays definitive treatment and can result in the patient continuing to have disabling seizures. Option C ('Start epilepsy surgery workup') is the correct next step in accordance with current guidelines. It is the definitive recommended pathway for drug-resistant MTLE. 1. In drug-resistant MTLE, early surgical evaluation can significantly improve outcomes. 2. Two adequately tried AED regimens are enough to define drug resistance. 3. Minimizing long-term AED exposure is beneficial, especially for women of childbearing age. Recent guidelines from the ILAE and multiple epilepsy surgery centers advocate for early referral for surgical evaluation in cases of drug-resistant MTLE, particularly given the potential for superior seizure control and better quality-of-life outcomes post-surgery.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Elderly male, DM, HTN, DLP, IHD, HFrEF, presented with episode of loss of consciousness preceded by sweating and palpitation. There was short abnormal movements during the episode. The event lasted few seconds then he immediately regain full baseline. His BP was borderline low and HR 50 per minute. Which of these support your diagnosis? (Note: was typical syncope)",
    "option_a": "Rhythmic jerking",
    "option_b": "Multifocal myoclonus",
    "option_c": "Eyes uprolling",
    "option_d": "Oral automatism",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "The question requires differentiating between syncope (a transient loss of consciousness due to cerebral hypoperfusion) and epileptic seizures. Some syncopal episodes, particularly those with convulsive movements (\u2018convulsive syncope\u2019), can mimic seizures. During syncope, cerebral hypoperfusion leads to transient neuronal dysfunction. This can cause brief, nonrhythmic myoclonic jerks that are not the result of abnormal cortical discharges but rather the brain\u2019s response to hypoxia. In contrast, epileptic seizures typically involve hypersynchronous neuronal firing leading to rhythmic, stereotyped movements. This elderly patient, with cardiovascular co-morbidities and a clear prodrome (sweating, palpitation) followed by a brief loss of consciousness and immediate recovery, fits the profile of syncope. The presence of brief abnormal movements due to hypoperfusion is common in syncope and is typically multifocal and nonrhythmic. The workup includes an ECG, cardiac evaluation (e.g., echocardiogram, Holter monitor), and possibly tilt-table testing. Differential diagnoses include epileptic seizures (which usually show postictal confusion, stereotyped automatisms, and a clear ictal EEG pattern) and arrhythmia-induced syncope. Management involves addressing the underlying cardiovascular causes, medication review (especially for bradycardia or hypotension-inducing drugs), and lifestyle modifications. In elderly patients, detailed cardiac workup is essential. In pregnant or lactating patients with syncope, careful medication management and non-pharmacological strategies are emphasized to ensure maternal and fetal safety. Option A ('Rhythmic jerking') is more suggestive of a true seizure. Option B ('Multifocal myoclonus') correctly describes the irregular, brief movements seen in syncope. Option C ('Eyes uprolling') and Option D ('Oral automatism') are typically associated with epileptic seizures. Thus, Option B best supports the diagnosis of syncope with convulsive features. 1. Syncope can be accompanied by brief myoclonic jerks that are often mistaken for seizures. 2. The immediate recovery after the event, without a postictal period, is a key clue to syncope. 3. A careful history that includes prodromal symptoms is essential in differentiating syncope from seizures. Recent studies reaffirm the importance of detailed clinical history and cardiac evaluation in cases of syncope. Advanced monitoring and tilt-table testing have proven valuable in distinguishing syncope with convulsive movements from epileptic seizures.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Young male with nocturnal hyperkinetic movements at right, facial clonic spells and profuse salivation, sometimes evolve to GTCS. Diagnosis of ADNFLE was established, where is the site of seizure focus?",
    "option_a": "Orbitofrontal area",
    "option_b": "Frontal operculum",
    "option_c": "SMA",
    "option_d": "Dorsolateral prefrontal",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) is a genetic epilepsy syndrome characterized by hyperkinetic and motor seizures during sleep. Localization of the seizure focus is central to understanding its clinical manifestations. ADNFLE is often linked to mutations affecting nicotinic acetylcholine receptors, leading to abnormal excitability in the frontal lobe. While the seizures can originate from various areas within the frontal lobe, the semiology often reflects the functional anatomy; for instance, involvement of regions controlling facial movements may produce clonic movements and salivation. The patient\u2019s nocturnal hyperkinetic movements, right-sided facial clonic spells, and profuse salivation suggest involvement of the region that controls facial motor activity. The frontal operculum, which encompasses parts of the inferior frontal region responsible for orofacial motor functions, is most consistent with these symptoms. In contrast, the supplementary motor area (SMA) tends to produce more bilateral or axial manifestations. The evaluation of ADNFLE involves video-EEG monitoring (ideally capturing events during sleep), high-resolution MRI, and possibly genetic testing. Differential diagnoses include nocturnal frontal lobe epilepsy of other etiologies, parasomnias, and frontal lobe behavior disorders. The precise semiology and lateralization (facial clonic activity and salivation) help distinguish an opercular focus from other frontal areas. Management of ADNFLE typically involves the use of carbamazepine, which is effective for many patients. For refractory cases, further AED adjustments or evaluation for surgical intervention may be considered. In pregnant or lactating patients, medication choice must carefully balance efficacy with teratogenic risk, and in selected cases, surgery might be postponed until after delivery unless risks outweigh benefits. Option A (Orbitofrontal area) may be considered in some cases of frontal epilepsy but does not best explain prominent orofacial symptoms. Option B (Frontal operculum) is correct because it is anatomically associated with orofacial motor control, matching the patient\u2019s spells of facial clonic movements and salivation. Option C (SMA) typically produces bilateral or axial motor phenomena, which is less consistent with the lateralized facial symptoms. Option D (Dorsolateral prefrontal) is mostly linked to cognitive functions rather than motor manifestations. 1. ADNFLE is best suspected in patients with stereotyped nocturnal hypermotor seizures and familial history. 2. Orofacial symptoms such as facial clonic movements and salivation point toward an opercular focus. 3. Video-EEG during sleep is critical for accurate localization. Recent research on ADNFLE emphasizes the heterogeneity of frontal lobe seizure origins; however, phenotypic features, particularly orofacial automatisms, strongly support a seizure focus in the frontal operculum. Updated genetic studies further characterize the role of nicotinic receptor mutations in these cases.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "7 years old boy has frequent focal seizures in right body sometimes evolving to epilepsia partialis continua. On examination he has right side weakness and his MRI shows perisylvian atrophy. Which of the following antibodies is likely to present in his serum/CSF?",
    "option_a": "mGLURS",
    "option_b": "NMDA",
    "option_c": "mGLUR3",
    "option_d": "Caspr2",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "This case describes a child with focal seizures affecting the right side of his body, sometimes progressing to epilepsia partialis continua, along with right\u2010sided weakness and perisylvian atrophy on MRI \u2013 findings highly suggestive of Rasmussen encephalitis, an inflammatory, usually unihemispheric disease of childhood. Historically, researchers have linked Rasmussen encephalitis to autoimmunity, particularly with antibodies directed against glutamate receptor subunits. Rasmussen encephalitis is believed to be an autoimmune encephalitis where antibodies, notably anti-GluR3 (the glutamate receptor 3 subtype), target neuronal elements. This immune reaction leads to chronic inflammation, excitotoxicity, and subsequent atrophy of the affected hemisphere. Although the exact role of these antibodies remains a subject of research, their presence has been associated with the pathological process in many cases. The clinical picture \u2013 focal seizures beginning in one limb region, progression to epilepsia partialis continua, and corresponding contralateral weakness \u2013 reflects the inflammatory destruction and functional impairment of one cerebral hemisphere. The characteristic unilateral atrophy seen on MRI (perisylvian in this case) reinforces the diagnosis. Diagnosis is based on clinical findings, characteristic EEG changes, and MRI evidence. Differential diagnoses include focal cortical dysplasia, tuberous sclerosis (which often has additional systemic manifestations), and other causes of focal epilepsy. Detection of anti-GluR3 antibodies in serum or CSF supports an autoimmune etiology, though their absence does not exclude the diagnosis. First-line management includes immunomodulatory therapies such as high-dose corticosteroids, intravenous immunoglobulin (IVIG), and plasmapheresis to try to slow disease progression. Anti-epileptic drugs (AEDs) are used for seizure control; however, medical therapy is often insufficient. In advanced cases, functional hemispherectomy may be considered. While pregnancy/lactation issues are generally not a concern in a 7-year-old, for female patients reaching childbearing age, the teratogenic potential of AEDs and immunosuppressive agents must be carefully managed. Option A (mGLURS) is non-specific and does not denote the particular receptor subtype implicated. Option B (NMDA) is associated with anti-NMDA receptor encephalitis, which typically presents with neuropsychiatric features in young women. Option C (mGLUR3) correctly identifies the antibody historically linked to Rasmussen encephalitis. Option D (Caspr2) is more often seen in disorders such as Morvan syndrome or neuromyotonia. \u2022 Rasmussen encephalitis typically presents in children with unilateral, drug-resistant focal seizures and progressive neurological deficits. \n\u2022 The association with anti-GluR3 antibodies, while historically significant, is not universally observed and remains an area of active research. Recent studies stress the importance of early immunomodulatory treatment to potentially slow progression, although definitive evidence is still evolving. The pathogenic role of anti-GluR3 antibodies has been questioned in some recent research, and current guidelines emphasize a multimodal treatment approach rather than reliance on antibody status alone.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "https://drive.google.com/file/d/1kD9Y7vIjnI3jlbZSt_61Z9jDQkd1iu_F/preview"
  },
  {
    "question": "2 years old boy has hypsarrhythmia on EEG, mental regression, infantile spasm.",
    "option_a": "West syndrome",
    "option_b": "TSC",
    "option_c": "Joubert",
    "option_d": "LGS",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "West syndrome is an epileptic encephalopathy of infancy characterized by the triad of infantile spasms, a distinctive chaotic EEG pattern known as hypsarrhythmia, and developmental regression. It typically presents in the first years of life. The syndrome results from various underlying brain injuries or metabolic disorders that lead to diffuse cerebral dysfunction. The EEG hallmark, hypsarrhythmia, reflects disorganized and chaotic neuronal activity, which contributes to the clinical manifestations and developmental delay observed in affected infants. In this 2-year-old boy, the presence of hypsarrhythmia on EEG alongside clinical signs of infantile spasms and mental regression fits the classic picture of West syndrome. Early identification is critical as prompt treatment can improve developmental outcomes. Key differentials include other causes of infantile seizures such as tuberous sclerosis (which would have additional skin and organ findings), and less commonly other encephalopathies. The EEG pattern of hypsarrhythmia is particularly diagnostic for West syndrome. First-line treatment generally includes adrenocorticotropic hormone (ACTH) or high-dose steroids. Vigabatrin is especially considered when West syndrome is associated with tuberous sclerosis. Additional AEDs may be used if needed. In future management of female patients during pregnancy or lactation, careful risk-benefit analysis of AEDs is essential due to potential teratogenicity. Option A (West syndrome) is the classic diagnosis given the combination of infantile spasms, hypsarrhythmia, and mental regression. Option B (TSC) can be associated with infantile spasms but typically includes other clinical findings such as skin lesions. Option C (Joubert) has a distinct neurological and radiological profile (eg, the molar tooth sign) unrelated to hypsarrhythmia. Option D (Lennox-Gastaut syndrome) is an epileptic encephalopathy that develops later in childhood and has a different EEG pattern. \u2022 Early recognition and treatment of West syndrome are vital to potentially improve long-term developmental outcomes. \n\u2022 Hypsarrhythmia on EEG is a hallmark and should prompt urgent therapeutic intervention. Recent guidelines continue to advocate for early treatment with ACTH or steroids. There is also growing evidence supporting the use of vigabatrin in tuberous sclerosis-associated cases. Ongoing research focuses on optimizing treatment protocols and improving neurocognitive outcomes in these infants.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Which true regarding LGS?",
    "option_a": "Onset between 3-15 years",
    "option_b": "Drug resistant epilepsy",
    "option_c": "Has good prognosis",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Lennox-Gastaut syndrome (LGS) is a severe childhood epileptic encephalopathy characterized by multiple seizure types, cognitive impairment, and a specific EEG pattern. It is notorious for its resistance to conventional anti-epileptic drug therapy. LGS involves widespread cerebral dysfunction, often stemming from an underlying structural brain abnormality, genetic mutation, or prior brain injury. The epileptogenic processes are typically diffuse, contributing to drug resistance and progressive cognitive decline. The syndrome\u2019s hallmark is the presence of multiple seizure types \u2013 including tonic, atonic, and atypical absence seizures \u2013 that are highly refractory to medical management. The cognitive and behavioral impairments seen in LGS further complicate the clinical course. Diagnosis primarily relies on the clinical history and characteristic EEG findings (slow spike-wave complexes on interictal EEG). Differential considerations include West syndrome (which presents earlier with a different EEG pattern) and other epileptic encephalopathies such as Dravet syndrome. The first-line management of LGS involves combination therapy with multiple AEDs. Adjunctive therapies include the ketogenic diet, vagal nerve stimulation (VNS), and in select cases, surgical interventions. Newer therapies such as cannabidiol have shown promise. In female patients of childbearing age, the teratogenic risks of several AEDs must be carefully considered during pregnancy and lactation, with appropriate counseling and planning. Option A (Onset between 3-15 years) is misleading because although there is some variability in age of onset, LGS most commonly begins between 2 and 8 years and is better known for its severe, refractory nature rather than age range. Option B (Drug resistant epilepsy) is correct, as drug resistance is a defining feature of LGS. Option C (Has good prognosis) is incorrect since LGS is associated with a poor neurological and developmental outcome. \u2022 LGS is one of the most refractory forms of epilepsy seen in children and often requires multimodal therapy. \n\u2022 The syndrome is associated with significant cognitive and behavioral challenges, necessitating comprehensive, multidisciplinary management. Recent research has validated the use of adjunctive therapies such as the ketogenic diet and cannabidiol, with emerging guidelines incorporating these therapies into treatment algorithms for LGS. Continuous updates in AED management have also stressed the importance of individualized therapy, particularly when considering future pregnancy and lactation in female patients.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Patient sustained MVA with moderate head trauma. For how long his post traumatic epilepsy risk takes?",
    "option_a": "5 years",
    "option_b": "10 years",
    "option_c": "15 years",
    "option_d": "30 years",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Post-traumatic epilepsy (PTE) refers to the development of recurrent seizures following a traumatic brain injury (TBI). The risk period for developing epilepsy after a head injury is a key point of clinical interest, as it defines the window during which patients remain at an elevated risk compared to the general population. Moderate head trauma can trigger a cascade of events including blood-brain barrier disruption, neuroinflammation, gliosis, and formation of aberrant neuronal circuits. These changes contribute to the development of an epileptogenic focus that may manifest as clinical seizures months to years following the injury. Clinically, patients who have sustained moderate head trauma may experience seizures not acutely but over a prolonged period. The median time to onset of post-traumatic epilepsy is variable; while many seizures occur within the first two years, an increased lifetime risk has been documented, particularly within a period of up to 10 years post-injury. Diagnosis is primarily clinical, based on the patient\u2019s history of TBI and exclusion of other causes of epilepsy. Differential diagnoses include idiopathic epilepsy, vascular malformations, and post-stroke epilepsy. Long-term follow-up and careful electroclinical evaluation are key to distinguishing PTE from other epileptic disorders. Acute seizure prophylaxis with antiepileptic drugs is recommended in the early period (typically within the first 7 days) for high-risk patients, though it does not reduce the long-term incidence of PTE. Long-term management focuses on appropriate seizure control once epilepsy is established. In pregnant or lactating women with a history of TBI and subsequent PTE, AED selection must be carefully tailored to minimize teratogenic risks while ensuring effective seizure control. Option A (5 years) underestimates the recognized period of increased risk. Option B (10 years) is correct according to multiple epidemiologic studies that indicate an elevated risk for up to a decade following moderate head injury. Option C (15 years) and Option D (30 years) overestimate the typical reported risk period in most current literature. \u2022 Even after moderate head trauma, patients remain at an increased risk for epilepsy for several years; most epidemiologic data support a risk period of up to 10 years. \n\u2022 Early post-traumatic seizures (within the first week) are managed differently from late seizures which represent true epileptogenesis. Recent epidemiological research supports that the risk of post-traumatic epilepsy remains significantly elevated for up to 10 years following moderate TBI. Current guidelines emphasize that while short-term prophylaxis may reduce early seizures, it does not alter the long-term risk, underscoring the need for extended follow-up and patient education.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Young male with first time generalized tonic clonic seizure during daytime. No previous seizures. No epilepsy risk factors. Exam + MRI + EEG normal. 2 year recurrence?",
    "option_a": "10%",
    "option_b": "30%",
    "option_c": "50%",
    "option_d": "77%",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "After a first unprovoked seizure, the risk of recurrence is estimated based on clinical and paraclinical findings. In a young man with a normal exam, normal MRI and EEG, no risk factors are present, so the estimated recurrence risk over 2 years is moderate. Seizure recurrence reflects an underlying predisposition of the brain to generate abnormal synchronized electrical discharges. Even when imaging and EEG are normal, a latent epileptogenic process may be present without structural or electrophysiological markers. Factors such as abnormal neuronal connectivity or subclinical metabolic imbalances may still exist. Clinically, patients presenting with a first unprovoked generalized tonic-clonic seizure and normal workup are reassured by the absence of overt lesions or epileptiform activity; however, the risk of recurrence remains substantial. This informs the decision-making regarding initiation of antiepileptic treatment after the first event. The evaluation includes ruling out provoked causes (e.g., electrolyte disturbances, infections, drugs), confirming the absence of structural lesions on MRI, and performing an EEG. Differential diagnoses include syncope, psychogenic nonepileptic seizures, and metabolic events, which are differentiated by history, context, and appropriate workup. Current guidelines suggest that routine immediate antiepileptic drug (AED) therapy after a first unprovoked seizure is controversial, given the moderate recurrence risk (around 30% over 2 years in low-risk patients). A tiered approach involves: (1) detailed counseling, (2) further risk stratification if indicated, and (3) initiation of AEDs if additional risk factors or subsequent events occur. Pregnancy/lactation considerations are not directly relevant here since the patient is a young male. Option A (10%) underestimates the recurrence risk; Option B (30%) correctly reflects the approximate risk found in studies of patients with normal investigations; Option C (50%) and D (77%) overestimate the risk for this low-risk scenario. \u2022 A normal EEG and MRI do not eliminate the risk of seizure recurrence. \u2022 Most first unprovoked seizures carry an approximate 30% 2-year recurrence risk, informing conservative management. \u2022 Counseling on lifestyle modifications and safety is crucial even when tests are normal. Recent reviews and guidelines from neurological societies confirm that in patients without risk factors (normal neuroimaging and EEG), the 2-year recurrence risk is in the range of 30%, supporting a conservative approach rather than immediate lifelong therapy.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "WOTF is expected normal EEG findings during hyperventilation?",
    "option_a": "Generalized delta waves",
    "option_b": "Predominant frontal delta/theta waves activity",
    "option_c": "Couldn't read",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Hyperventilation is an activation procedure used during EEG recordings to provoke abnormalities, particularly in conditions like absence epilepsy. Even in normal individuals, controlled hyperventilation can induce benign changes. Hyperventilation reduces arterial CO2 (hypocapnia) leading to cerebral vasoconstriction and temporary alterations in neuronal excitability. This often results in a slowing of the background rhythm, typically noted in the frontal regions. In normal EEG studies, hyperventilation may produce mild slowing of the background rhythm with frontal predominance, usually in the theta range or sometimes low delta/theta. These changes, when transient and not associated with epileptiform discharges, are considered normal. When interpreting an EEG during hyperventilation, distinguishing normal physiologic slowing from pathologic patterns (e.g., generalized spike-wave complexes in absence epilepsy) is crucial. Differential considerations include reactive changes due to hyperventilation versus abnormal slowing seen in structural encephalopathies. No specific treatment is indicated for a normal physiologic response to hyperventilation. In cases where abnormal EEG findings are induced, further clinical correlation is warranted. Pregnancy and lactation considerations do not apply here as this is a diagnostic test finding. Option A (Generalized delta waves) would be considered abnormal in an awake, cooperative adult. Option B (Predominant frontal delta/theta waves activity) correctly describes the expected benign slowing in the frontal regions during hyperventilation. Option C ('Couldn't read') is not a valid descriptive option. \u2022 Hyperventilation can physiologically induce slowing in the EEG, predominantly over the frontal regions. \u2022 Distinguishing between normal hyperventilation-induced slowing and pathologic patterns is key in EEG interpretation. \u2022 In absence epilepsy, hyperventilation often provokes generalized 3 Hz spike-wave discharges, which is different from normal slowing. Updated EEG interpretation guidelines confirm that a benign frontal slowing (in the delta/theta range) during hyperventilation in a normal adult is an expected activation phenomenon without pathologic significance.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Young female with epilepsy on Topopax has worsened difficulty concentration. She is willing to change to new ASM. Which choice is the best for her?",
    "option_a": "Lamotrigine",
    "option_b": "Zonisamide",
    "option_c": "Valproate",
    "option_d": "Levetiracetam",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Topiramate is a broad-spectrum antiseizure medication (ASM) but is well known for its cognitive side effects, including difficulties with concentration and word-finding. Switching to an ASM with a more favorable cognitive profile is advisable for patients troubled by these adverse effects. Topiramate\u2019s mechanism involves enhancement of GABA activity, antagonism of glutamate receptors, and inhibition of carbonic anhydrase, all of which contribute to cognitive slowing and concentration difficulties. Lamotrigine, in contrast, primarily works through voltage-gated sodium channel blockade, which is generally associated with less cognitive impairment. In young female patients, particularly those of childbearing potential, the choice of an ASM should take into account both efficacy and side-effect profile. Cognitive preservation is a priority, and lamotrigine tends to be more favorable in minimizing cognitive deficits compared to topiramate or zonisamide. Before switching ASMs, a thorough review of the patient\u2019s seizure control, side effect profile, and potential drug interactions is warranted. Differential considerations for cognitive slowing include depression, sleep disturbances, or other medication effects that need to be differentiated by clinical history and review. The first-line management for a patient experiencing cognitive side effects from topiramate is to consider a switch to an alternative ASM. Lamotrigine is recommended as a switch option given its efficacy and tolerability. In pregnancy, lamotrigine is associated with lower teratogenic risk relative to valproate, though levels may fluctuate during pregnancy and require monitoring. A careful, gradual titration is recommended when switching medications. Option A (Lamotrigine) is appropriate due to its better cognitive profile and safety in young women. Option B (Zonisamide) is known to similarly affect cognition and is less favorable. Option C (Valproate) is avoided in women of childbearing potential because of significant teratogenic risk. Option D (Levetiracetam) can cause behavioral side effects and has variable effects on cognition, making it a less ideal switch compared with lamotrigine. \u2022 Topiramate is frequently associated with attention and concentration difficulties; a switch to lamotrigine can improve cognitive functioning. \u2022 Lamotrigine is considered relatively safe in pregnancy but requires monitoring for dose adjustments. \u2022 Always consider the patient\u2019s reproductive plans when choosing an ASM. Recent guidelines from epilepsy societies endorse lamotrigine as a first-line agent in many forms of epilepsy, notably for women where cognitive and teratogenic considerations are paramount. Studies confirm its superior cognitive tolerability compared to topiramate.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Seizure described as early non forced right head turn, right hand automatisms. Localization?",
    "option_a": "Right frontal lobe",
    "option_b": "Right temporal lobe",
    "option_c": "Left temporal",
    "option_d": "Left frontal",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Seizure semiology, or the detailed description of a seizure\u2019s clinical manifestations, provides vital clues to the localization of the epileptogenic focus. Features such as automatisms and head turning can help pinpoint the lobe involved. Temporal lobe seizures are characterized by complex partial events that often include automatisms (e.g., right-hand movements) and a non-forced head turn. In temporal lobe epilepsy, ictal activity typically spreads to involve networks that cause ipsilateral motor features without the forcible deviation seen in frontal lobe seizures. The early, non-forced right head turn accompanied by right hand automatisms suggests that the seizure originates in the right temporal lobe. In contrast, forced head version is more consistent with involvement of the contralateral frontal regions. Differential diagnosis for focal seizures includes frontal lobe epilepsy, which may show more abrupt onset and often involves forced head turning, versus temporal lobe epilepsy which is slower in onset and features complex automatisms. Detailed video-EEG monitoring can help in differentiating these. Management involves appropriate ASM therapy tailored to the seizure type; temporal lobe epilepsy is often managed with agents such as lamotrigine, levetiracetam, or carbamazepine. For patients refractory to medical management, surgical evaluation may be considered. In women of childbearing age, lamotrigine is often preferred due to a more favorable teratogenic profile. Option A (Right frontal lobe) is less likely because frontal lobe seizures more typically exhibit forced, often contralateral head version without classic automatisms. Option B (Right temporal lobe) is correct based on the ipsilateral, non-forced head turn and right hand automatisms. Option C (Left temporal) and Option D (Left frontal) are excluded because the lateralizing signs point to the right hemisphere. \u2022 Non-forced head turning during a seizure is typically ipsilateral to the epileptogenic focus in temporal lobe epilepsy. \u2022 Automatisms such as repetitive hand movements strongly suggest temporal lobe involvement. \u2022 Detailed seizure semiology is critical to accurate localization and subsequent management. Modern neurophysiological research and video-EEG studies continue to validate the significance of ictal semiology in seizure localization. Current guidelines emphasize the role of detailed clinical history and video monitoring in establishing the precise epileptogenic zone for optimal management.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "23 years old female brought to the clinic by her husband who said she has hyperactive jerky movements especially during sleep. No epilepsy risk factors. EEG shows frontal lobe epileptic spike and waves. What is the best AED for her?",
    "option_a": "Valproate",
    "option_b": "Phenytoin",
    "option_c": "Lacosamide",
    "option_d": "Levetiracetam",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Epilepsy",
    "explanation": "This question focuses on selecting an appropriate antiepileptic drug (AED) for a young woman with focal seizures. The patient exhibits hyperactive, jerky movements during sleep and an EEG showing frontal lobe spikes, suggesting focal-onset seizures. When treating women of child\u2010bearing potential, the safety profile regarding teratogenicity is paramount. Focal seizures, such as those originating from the frontal lobe, result from abnormal, localized hyperexcitability of cortical neurons. Sleep can alter the balance of excitatory and inhibitory neurotransmitters, potentially lowering the threshold for seizure activity. Abnormal discharge patterns (spikes and waves) on EEG confirm a localized epileptic focus. The patient\u2019s jerky movements during sleep correlate with motor phenomena seen in focal motor seizures. The EEG finding of frontal spikes further supports a focal rather than a generalized epilepsy syndrome. In women of childbearing age, choosing an AED with a better teratogenic profile is important. Key differentials include nocturnal frontal lobe epilepsy versus myoclonic seizures seen in juvenile myoclonic epilepsy. However, the focal EEG abnormalities (frontal lobe spikes) help distinguish focal onset seizures from generalized conditions. Additional evaluation may include detailed history, video-EEG monitoring, and neuroimaging when indicated. First-line management for focal seizures typically includes AEDs with efficacy in localized epilepsies. Levetiracetam is preferred in women, given its effective seizure control and lower risk of teratogenicity compared to valproate. Second-line options might include other sodium channel\u2010blocking agents (such as carbamazepine) though their side effect profile and drug interactions can be less favorable in young females. Pregnancy and lactation considerations are crucial; levetiracetam has a comparatively favorable safety profile in these settings, making it a good choice for women of child\u2010bearing potential. Option A (Valproate) is effective for various types of seizures but is teratogenic and generally avoided in women of reproductive potential. Option B (Phenytoin) has a more problematic side effect and drug interaction profile. Option C (Lacosamide) is used for focal seizures but is not typically first-line in young women when alternatives with proven safety exist. Option D (Levetiracetam) provides effective seizure control in focal epilepsy and a better safety profile in women \u2013 making it the best choice. 1. Always consider teratogenicity when selecting AEDs in women of child-bearing potential. 2. Focal epilepsies with frontal onset may present with nocturnal motor phenomena. 3. Levetiracetam is well tolerated and has relatively few drug\u2010drug interactions. Recent guidelines and studies support the use of levetiracetam for focal epilepsies due to its efficacy and safety profile in women. Its broad spectrum of activity and lower teratogenic risk compared to valproate has been highlighted in several recent neurology consensus statements.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "https://drive.google.com/file/d/1Eel7IVvZbcYLUUI-siWND9KI2CRiysMa/preview"
  },
  {
    "question": "Which EEG finding is the best prognostic value in a 7-year-old boy who has frequent staring spells especially at school? NB: Was typical childhood absence seizure.",
    "option_a": "Seizure offset?",
    "option_b": "Seizure onset?",
    "option_c": "Normal background activities",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Childhood absence epilepsy (CAE) is a common pediatric epilepsy syndrome characterized by frequent, brief staring spells. The core diagnostic clue is a typical EEG pattern with generalized 3 Hz spike-and-wave discharges superimposed on a normal background. CAE involves disturbances in the thalamocortical circuitry, where abnormal rhythmic oscillations lead to the typical absence seizures. The presence of a normal background indicates that, aside from the paroxysmal discharges, the brain's electrical activity remains organized. In a 7-year-old with frequent staring spells, a normal background EEG is associated with a good prognosis. This normality is reassuring; it generally indicates that the epileptic process is otherwise limited and not associated with more diffuse cerebral dysfunction. Differential diagnoses include atypical absence seizures (which may occur with a disorganized or abnormal background as seen in Lennox-Gastaut syndrome) and non-epileptic staring episodes (such as daydreaming). Clear-cut 3 Hz spike-and-wave patterns with a normal background are pathognomonic for CAE. First-line treatment for CAE includes ethosuximide (when seizures are exclusively absence type) or valproate (if other seizure types coexist). In pediatric patients, especially with a normal background EEG indicating a benign process, the prognosis is excellent with proper treatment. Pregnancy and lactation are not directly a concern in this pediatric population, but future counseling becomes relevant as children grow older. Option A (Seizure offset) and Option B (Seizure onset) are not recognized prognostic markers. Option C (Normal background activities) is the correct choice as it signifies a typical EEG pattern in CAE and is associated with a favorable prognosis. Option D is blank. 1. A normal background EEG in CAE is a good prognostic sign. 2. Characteristic 3 Hz spike-and-wave discharges are key to the diagnosis. 3. Early treatment in CAE can prevent cognitive and academic difficulties. Recent updates in pediatric neurology emphasize the importance of detailed EEG analysis. Studies confirm that children with CAE and a normal background have a higher likelihood of complete remission and favorable long-term outcomes.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "61 years old male with DM, HTN, DLP, osteoporosis, and epilepsy. Which AED is suitable for him?",
    "option_a": "Phenytoin",
    "option_b": "Valproate",
    "option_c": "Carbamazepine",
    "option_d": "Lamotrigine",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Epilepsy",
    "explanation": "This question emphasizes the selection of an AED accounting for the patient\u2019s age and comorbid conditions. In older patients, particularly those with multiple comorbidities, the side effect profile, drug interactions, and impact on comorbidities (such as osteoporosis) are essential considerations. Epilepsy in older adults may have focal or generalized origins. While the underlying pathophysiology may involve altered neuronal excitability due to vascular changes or neurodegeneration, selecting an AED with fewer systemic effects is crucial due to the patient\u2019s comorbidities. The 61-year-old male\u2019s history of diabetes, hypertension, dyslipidemia, osteoporosis, and epilepsy calls for an AED that minimizes adverse effects including worsening bone health and drug-drug interactions. Lamotrigine works by stabilizing neuronal membranes via sodium channel blockade and has a favorable side effect profile in the elderly. While the diagnosis of epilepsy is already established, considerations in this patient include differentiating between focal and generalized seizure types, assessing his other medications, and evaluating bone health. Differential AED choices are refined based on these factors. First-line AEDs for elderly patients typically include lamotrigine and levetiracetam. Lamotrigine is favored because it has a low risk of drug interactions, does not induce hepatic enzymes, and has a minimal impact on bone metabolism. Second-line options like phenytoin and carbamazepine are less suitable because they can worsen osteoporosis and interact with other medications. Pregnancy and lactation are not directly considered in this 61-year-old male; however, similar principles guide AED selection in vulnerable populations. Option A (Phenytoin) is less desirable because of its narrow therapeutic index and potential for worsening osteoporosis. Option B (Valproate) has metabolic side effects and is less ideal for someone with dyslipidemia and osteoporosis. Option C (Carbamazepine) is an enzyme inducer and may have drug interactions and adverse effects on bone health. Option D (Lamotrigine) is the best choice given its efficacy, safety profile, and minimal adverse effects in an older patient with multiple comorbidities. 1. In elderly patients, always consider AEDs with minimal drug interactions and side effects. 2. Enzyme-inducing AEDs like phenytoin and carbamazepine can exacerbate comorbid conditions. 3. Lamotrigine is well tolerated in older populations. Current guidelines in geriatric neurology support the use of lamotrigine for focal and generalized seizures in older adults. Its safety profile, particularly regarding bone health and cardiovascular interactions, has been reiterated in recent consensus statements.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Long scenario 6 months old body with typical infantile spasm + developmental delay + EEG SHOWED HYPSARRHYTHMIA?",
    "option_a": "West syndrome",
    "option_b": "Dravet",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This scenario is a classic description of West syndrome, which is characterized by a triad: infantile spasms (typical seizures), developmental delay or regression, and a characteristic EEG pattern known as hypsarrhythmia. West syndrome involves a disruption in the early developing brain, with a heterogeneous etiology that can include genetic, metabolic, or structural abnormalities. The chaotic, high-amplitude, and disorganized EEG pattern (hypsarrhythmia) reflects widespread cortical dysfunction. Infants around 6 months presenting with clusters of spasms accompanied by developmental delays and an EEG showing hypsarrhythmia are highly indicative of West syndrome. Recognizing this early is critical because delayed treatment can adversely affect neurodevelopment. The differential diagnosis for infantile spasms includes other epileptic encephalopathies such as Dravet syndrome or Ohtahara syndrome. However, the presence of hypsarrhythmia on EEG, along with the age of onset and developmental delay, makes West syndrome the prototypical diagnosis. First-line treatment for West syndrome generally includes adrenocorticotropic hormone (ACTH) or high-dose oral steroids. Vigabatrin is another option, particularly when the syndrome is associated with tuberous sclerosis. Pregnancy and lactation considerations are less directly applicable to the infant; however, if the mother is lactating, the potential transfer of medications via breast milk should be evaluated and discussed with pediatric and maternal experts. Option A (West syndrome) is correct as the clinical scenario (infantile spasms, developmental delay, and hypsarrhythmia on EEG) is diagnostic for West syndrome. Option B (Dravet syndrome) is incorrect because, despite also being a severe infantile epilepsy syndrome, Dravet typically presents with prolonged febrile seizures and does not show the typical EEG pattern of hypsarrhythmia. Options C and D are blank. 1. The triad of infantile spasms, developmental delay, and hypsarrhythmia is pathognomonic for West syndrome. 2. Early diagnosis and treatment are crucial for improving long-term neurodevelopmental outcomes. 3. Vigabatrin is particularly effective if tuberous sclerosis is the underlying cause. Recent evidence and consensus guidelines emphasize the importance of early intervention in West syndrome, with ACTH and vigabatrin being the mainstays of treatment. Ongoing research is focused on the long-term cognitive and developmental outcomes following early and aggressive treatment.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Long scenario that patient presented to ER with history of 3 unprovoked seizures all labs is normal, and now she returns to baseline (they did not mention if it's within 24 hrs or no). What you will do?",
    "option_a": "Give AED",
    "option_b": "Don't give AED, OPD with MRI and EEG",
    "option_c": "Give AED and discharge with OPD / EEG and MRI",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Epilepsy is defined by the occurrence of two or more unprovoked seizures, with a significantly increased risk of recurrence. In this scenario, the patient has already experienced three unprovoked seizures, which meets the criteria for an epilepsy diagnosis, thus warranting treatment with an anti-epileptic drug (AED). Unprovoked seizures indicate an underlying neuronal hyperexcitability that may be due to genetic predisposition or subtle structural abnormalities not detected on basic laboratory workup. Although normal labs help exclude acute metabolic causes, they do not rule out an inherent epileptogenic focus that might be detected later with specialized studies like EEG or MRI. Clinically, patients with repeated unprovoked seizures are at high risk for further episodes, which can lead to injury or additional neurological compromise. Even if the patient returns to baseline after each event, the high recurrence risk justifies early intervention to prevent additional seizures. The initial workup includes laboratory tests to exclude provoked causes followed by neuroimaging (preferably MRI) to assess for structural abnormalities and an EEG to evaluate the electrical activity of the brain. Differential diagnoses include syncope, psychogenic non-epileptic seizures, and metabolic disturbances, which are generally ruled out by combining history, laboratory studies, and neurophysiological testing. According to the latest guidelines, once a patient has had two or more unprovoked seizures, initiating AED therapy is recommended. First-line management is to start an appropriate AED based on seizure type while arranging outpatient follow-up for more detailed neurophysiologic (EEG) and neuroimaging (MRI) evaluation. In women of childbearing potential, drug selection must consider teratogenic risks; counseling and the use of folate supplementation are essential. Option A (Give AED) is incomplete because it omits the necessary outpatient workup. Option B (Don't give AED, OPD with MRI and EEG) is not acceptable after multiple unprovoked seizures due to the high risk of recurrence. Option C (Give AED and discharge with OPD/EEG and MRI) is the most comprehensive, addressing both immediate seizure prevention and further diagnostic evaluation. Option D is not provided. 1. Two or more unprovoked seizures establish the diagnosis of epilepsy. 2. Early initiation of AED therapy is crucial to reduce recurrence risk. 3. Outpatient EEG and MRI are key for further classification and tailoring of therapy. Recent ILAE and AAN guidelines support starting AED treatment after the second unprovoked seizure, especially in patients with additional risk factors for recurrence. Advanced neuroimaging and EEG techniques further refine classification and management strategies.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Normal response of hyperventilation?",
    "option_a": "Generalized delta wave",
    "option_b": "Anterior theta/delta wave",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Hyperventilation is routinely used during EEG recordings as an activation procedure to help reveal underlying epileptiform activity. Its typical effect in normal individuals includes inducing a predictable pattern of electrical slowing. Hyperventilation leads to a reduction in arterial CO2 (hypocapnia), resulting in cerebral vasoconstriction and a transient decrease in cerebral blood flow. This, in turn, causes a slowing of the EEG background activity, particularly in the frontal (anterior) regions. During an EEG, the normal response to hyperventilation is the appearance of slow waves\u2014typically in the theta frequency range\u2014with an anterior predominance. This is in contrast to a generalized delta activity that would suggest more diffuse or pathological brain dysfunction. When interpreting EEG results, it is important to differentiate between normal physiologic slowing due to hyperventilation and abnormal generalized slowing, which may indicate encephalopathy. Differential diagnoses include metabolic encephalopathy and toxic states, where generalized, irregular slow waves are more prevalent. While there is no specific management required for a normal hyperventilation response, understanding this phenomenon helps prevent misinterpretation of EEG findings. In the context of suspected epilepsy, hyperventilation may help unmask abnormal discharges in patients with conditions such as absence seizures. Option A (Generalized delta wave) is incorrect because generalized delta activity implies a more widespread abnormality rather than the focal anterior slowing seen with normal hyperventilation. Option B (Anterior theta/delta wave) correctly describes the normal EEG slowing pattern seen during hyperventilation. Options C and D are not provided. 1. Hyperventilation typically produces anterior slowing (theta/delta) in a normal EEG. 2. Recognize that generalized delta activity is usually pathologic. 3. Hyperventilation remains a valuable activation technique in EEG studies. Contemporary EEG studies continue to validate hyperventilation as a safe and effective method to activate latent epileptiform discharges, with current research focusing on refining its parameters for optimal yield without provoking adverse responses.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario of Lennox Gastaut epilepsy what you will give??",
    "option_a": "Carbamazepine",
    "option_b": "Depakine",
    "option_c": "Keppra",
    "option_d": "is not provided.",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy characterized by multiple seizure types, cognitive impairment, and characteristic EEG findings. It often starts in childhood and is notoriously resistant to treatment. LGS involves widespread cortical dysfunction and abnormal synaptic activity, which contributes to a variety of seizure types (e.g., tonic, atonic, atypical absence). The underlying neuronal network abnormalities often result in treatment-resistant seizures. Patients with LGS typically present with multiple seizure types and developmental delays. The EEG in LGS characteristically shows slow spike-and-wave complexes, and seizure management is challenging due to the multifocal and refractory nature of the condition. The diagnosis of LGS is based on clinical history, EEG findings (slow spike-and-wave patterns), and cognitive assessment. The differential diagnosis includes other epileptic encephalopathies such as Dravet syndrome; careful evaluation of seizure types and developmental history helps in differentiation. Current guidelines recommend valproate (Depakine) as a first-line option for LGS due to its broad-spectrum efficacy. Other agents like lamotrigine, rufinamide, topiramate, and clobazam are often used as adjuncts. In women of childbearing potential, valproate's high teratogenic risk must be weighed carefully, and alternative regimens should be considered if possible. Option A (Carbamazepine) is contraindicated as it may exacerbate generalized seizures. Option B (Depakine/Valproate) is correct and is widely regarded as a first-line therapy for LGS. Option C (Keppra/Levetiracetam) is used as an adjunctive treatment rather than a first-line monotherapy in LGS. Option D is not provided. 1. Avoid sodium channel blockers like carbamazepine in generalized epilepsies such as LGS. 2. Valproate remains a cornerstone in the management of LGS despite its side effect profile. 3. EEG findings are a critical component of the diagnosis of LGS. Recent clinical guidelines and research continue to support valproate as a first-line treatment for LGS, although emerging therapies and combination approaches are being actively investigated to improve outcomes in this difficult-to-treat population.",
    "exam_year": "2022",
    "exam_type": "Part I"
  }
]